A pharmacokinetic study: ranibizumab, aflibercept and the effect of vitrectomy
Phase of Trial: Phase IV
Latest Information Update: 08 Feb 2016
At a glance
- Drugs Aflibercept (Primary) ; Ranibizumab (Primary)
- Indications Age-related macular degeneration
- Focus Pharmacokinetics
- Acronyms VITCLEAR
- 22 Jan 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Dec 2016 as reported by ClinicalTrials.gov.
- 14 Aug 2015 Planned primary completion date changed from 1 Jun 2015 to 1 Dec 2015, as reported by ClinicalTrials.gov.
- 20 Sep 2014 The comparator as aflibercept has been added to this trial, also title, endpoints are changed as per European Clinical Trials Database record.